Evidence map›Paper›PMID 39761949›Full record

ArticleAlcohol, clinical & experimental research2025

Co-administration of polyethylene glycol with binge ethanol reduces markers of intestinal and hepatic inflammation in C57BL/6J mice by diminishing ethanol absorption through the intestinal wall.

Tom Ryu, Keungmo Yang, Byung Young Choi, Won Gil Cho, Beom Sun Chung

Abstract read
In one paragraph

Article in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Biochemistry and biophysics reports · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tom RyuDepartment of Internal Medicine, Institute for Digestive Research, Digestive Disease Center, Soonchunhyang University College of Medicine, Seoul, Korea.
Keungmo YangDivision of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Byung Young ChoiDepartment of Anatomy, Yonsei University Wonju College of Medicine, Wonju, Korea.
Won Gil ChoDepartment of Anatomy, Yonsei University Wonju College of Medicine, Wonju, Korea.
Beom Sun ChungDepartment of Anatomy, Yonsei University Wonju College of Medicine, Wonju, Korea.ORCID https://orcid.org/0000-0002-3644-9120

Funding

National Research Foundation of Korea RS-2023-00238039
6 · The paper itself

Abstract

backgroundTherapeutic options for managing intestinal and hepatic inflammation associated with alcohol consumption, a prevalent health problem worldwide, remain unavailable. This study examines the potential efficacy of polyethylene glycol (PEG) in mitigating the intestinal and hepatic damage, employing a mouse model for assessment.

methodsFirst, the mixture of ethanol (4 g/kg body weight) and PEG (2 g/kg body weight) or an equivalent volume of vehicle was administered orally alcohol consumption.

resultsAcute alcohol consumption was found to damage not only the liver but also the small intestine, as evidenced by histological findings and mRNA expression analysis of inflammatory cytokines. We also identified impaired motor function in the mouse model of binge drinking. Interestingly, PEG significantly mitigated both the impaired motor function and the injury and inflammation of the small intestine following binge drinking in mice. Furthermore, PEG exhibited hepatoprotective effects, as indicated by reduced hepatic enzyme levels in serum, less liver injury observed through H & E staining, and decreased neutrophil infiltration within the liver.

conclusionsCollectively, these findings suggest that co-administration of PEG with binge ethanol could serve as an effective therapeutic strategy to prevent intestinal and hepatic inflammation.

Indexed as

alcoholbinge drinkingintestineliverpolyethylene glycol

Identifiers

PMID39761949
PMCPMC11828973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.